Leap Therapeutics (LPTX) Misses Q3 EPS by 8c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.08).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c